anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

154,201-154,260 of 319,975

filter-aware
10
The slide uses a numbered list (1-3) to map specific platform features to corresponding visual elements in the software screenshot.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
11
The slide uses a process-like flow from left (ML identification) to right (care outcomes).Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
12
The slide uses a two-column layout: left side details the value proposition/workflow, right side shows quantitative adoption metrics.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
13
The slide uses a 3x4 grid of metrics to quantify product-market fit and operational efficiency.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
14
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
16
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
17
MCR = Medical Cost Ratio. The slide highlights a 1,100 basis point differential in Q1 2020.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
18
The chart illustrates how Clover Assistant (CA) reduces MCR through revenue and medical expense differentials.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
19
The slide outlines a strategic roadmap for improving Star ratings through software feature releases and regulatory changes.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
20
The chart uses a 2x2 matrix style to show competitive positioning.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
21
The table compares PCP copays, specialist copays, drug deductibles, OTC allowances, and average annual/lifetime costs.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
22
Uses a funnel-like structure to represent population segments.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
23
The slide uses a grouped bar chart to demonstrate competitive positioning over time.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
24
Uses a hub-and-spoke diagram to represent the scalability of the core technology platform.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
25
The slide uses a hub-and-spoke diagram to illustrate how the Clover Assistant platform connects to different patient segments.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
26
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
27
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
28
The slide outlines a sequential or parallel operational playbook for market entry and scaling.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
29
The slide uses a three-column layout to break down the financial model, operational levers, and the value proposition of the Clover Assistant.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
30
The slide includes a disclaimer at the bottom noting that this is a design concept and not a live product screenshot.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
31
The slide includes a disclaimer note at the bottom regarding the prototype nature of the UI.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
32
The slide includes a disclaimer at the bottom stating this is a design concept and not a live product screenshot.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
33
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
34
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
35
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
36
The slide uses a table structure to define financial line items.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
37
Includes detailed footnotes explaining non-GAAP adjustments.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
38
The table includes Q1, Q2, and Q3 2020 data alongside YTD 2020 figures, with footnotes explaining specific line items.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
39
The chart illustrates the reconciliation of Medical Cost Ratio (MCR) adjustments.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
40
The slide includes detailed footnotes explaining the financial definitions and projections.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
41
The chart uses a waterfall bridge format to explain the delta between 2019 MCR and projected 2023 MCR scenarios.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
42
The slide presents a standard SPAC transaction capital structure breakdown.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
43
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
44
Uses a before-after comparison framework to highlight value proposition.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
45
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
46
The slide uses a comparison framework to highlight competitive differentiation.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
47
Includes a disclaimer regarding the inability to forecast net loss/income for future periods.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
01
Slide 1
Includes company logo and a scientific illustration of a protein structure.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank 1 hit
02
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank 1 hit
03
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank 1 hit
04
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
05
Includes logos for both team affiliations and investor base.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · TeamLoop · Golden Circle1 hit
06
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
07
The slide highlights technical capabilities and productivity metrics at the bottom.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a biological interaction map to demonstrate the breadth of the company's target library.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide shows a workflow from a 'toolbox of validated leads' to 'high-throughput expression & characterization' and finally to specific multi-specific constructs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a Gantt-style chart to show the progress of four distinct programs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses a timeline framework to track progress of four distinct programs (CTX-471 monotherapy, CTX-471 combo, CTX-8371, and NKp30 platform) plus future programs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a molecular structure diagram to illustrate the binding site differences between CTX-471 and existing therapies.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a before-after-bridge style framing to highlight the drug's superior efficacy compared to standard monotherapies.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
The slide uses a series of line charts to demonstrate efficacy across different antibody affinities.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The slide compares initial monotherapy survival against a re-challenge survival study.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
17
The diagram shows a multi-step process involving opsonization, NK cells, macrophages, dendritic cells (DC), and T-cell activation via CD137.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a series of small-multiple line charts to show tumor growth over time and a Kaplan-Meier survival curve to show efficacy.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
19
The slide includes a Kaplan-Meier plot showing PFS outcomes for different patient cohorts (PD-1 refractory, immune competent).Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
20
Includes a pharmacokinetic simulation graph and a conceptual dose-response curve illustrating that maximal receptor occupancy may not correlate with optimal biological response.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
21
The slide presents two distinct tables: one for patient demographics/clinical history and one for cancer indications.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
22
The slide uses red arrows for primary categories and blue arrows for sub-points.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit